Thrombocytopenia
2 competing products in clinical development for Thrombocytopenia.
Pipeline by Phase
Phase 11
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Avatrombopag + Placebo + Pegylated interferon (PEG-IFN) + Telaprevir + Ribavirin | Eisai | Phase 2 | Completed | 35 |
| avatrombopag | Eisai | Phase 1 | Completed | 29 |